To study mechanisms providing tumour resistance to endogenous IFNγ, we analysed primary TGCT and two human TGCT cell lines (NTERA and NCCIT) for the expression of IFNγ receptor and for the level of phosphorylation of the signal transducer and activator of transcription (STAT)-1. The gene discussed is IFNG; the disease is neoplasm.